{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:58:24Z","timestamp":1788357504951,"version":"build-2803163510"},"reference-count":106,"publisher":"Bioscientifica","issue":"3","content-domain":{"domain":["erc.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:p>Small intestinal neuroendocrine tumours (SI-NETs) are neoplasms characterized by their ability to secrete biogenic amines and peptides. These cause distinct clinical pathology including carcinoid syndrome, marked by diarrhoea and flushing, as well as fibrosis, notably mesenteric fibrosis. Mesenteric fibrosis often results in significant morbidity by causing intestinal obstruction, oedema and ischaemia. Although advancements have been made to alleviate symptoms of carcinoid syndrome and prolong the survival of patients with SI-NETs, therapeutic options for patients with mesenteric fibrosis are still limited. As improved insight in the complex pathogenesis of mesenteric fibrosis is key to the development of new therapies, we evaluated the literature for known and putative mediators of fibrosis in SI-NETs. In this review, we discuss the tumour microenvironment, growth factors and signalling pathways involved in the complex process of fibrosis development and tumour progression in SI-NETs, in order to elucidate potential new avenues for scientific research and therapies to improve the management of patients suffering from the complications of mesenteric fibrosis.<\/jats:p>","DOI":"10.1530\/erc-17-0380","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T20:20:13Z","timestamp":1513110013000},"page":"R115-R130","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":57,"title":["Small intestinal neuroendocrine tumours and fibrosis: an entangled conundrum"],"prefix":"10.1530","volume":"25","author":[{"given":"Anela","family":"Bla\u017eevi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Hofland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo J","family":"Hofland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Feelders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter W","family":"de Herder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"ref151","first-page":"1006","article-title":"Expression of platelet-derived growth factor and its receptors in neuroendocrine tumors of the digestive system.","volume":"52","year":"1992","journal-title":"Cancer Research"},{"key":"ref661","doi-asserted-by":"crossref","first-page":"383","DOI":"10.7326\/0003-4819-96-3-383_1","article-title":"Tamoxifen and carcinoid tumor","volume":"96","year":"1982","journal-title":"Annals of Internal Medicine"},{"key":"ref701","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/ijc.2910600514","article-title":"Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours","volume":"60","year":"1995","journal-title":"International Journal of Cancer"},{"key":"ref951","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/hep.29138","article-title":"Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells","volume":"66","year":"2017","journal-title":"Hepatology"},{"key":"ref791","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis.","volume":"19","year":"2013","journal-title":"Nature Medicine"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10555-006-8161-9","article-title":"A role for substance P in cancer promotion and progression: a mechanism to counteract intracellular death signals following oncogene activation or DNA damage","volume":"25","year":"2006","journal-title":"Cancer and Metastasis Reviews"},{"key":"ref281","first-page":"828","article-title":"High expression of growth factors and growth factor receptors in ovarian metastases from ileal carcinoids: An immunohistochemical study of 2 cases","volume":"122","year":"1998","journal-title":"Archives of Pathology and Laboratory Medicine"},{"key":"ref551","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/BF01658532","article-title":"Surgical treatment of mid-gut carcinoid tumors","volume":"14","year":"1990","journal-title":"World Journal of Surgery"},{"key":"ref931","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/08977194.2015.1054989","article-title":"Nerve growth factor exposure promotes tubular epithelial-mesenchymal transition via TGF-beta1 signaling activation","volume":"33","year":"2015","journal-title":"Growth Factors"},{"key":"ref1041","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1530\/EJE-16-0392","article-title":"Limited value for urinary 5-HIAA excretion as prognostic marker in gastrointestinal neuroendocrine tumours","volume":"175","year":"2016","journal-title":"European Journal of Endocrinology"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1440-1797.2011.01460.x","article-title":"Octreotide lessens peritoneal injury in experimental encapsulated peritoneal sclerosis model","volume":"16","year":"2011","journal-title":"Nephrology"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1200\/jco.2007.25.18_suppl.4504","article-title":"Mbib44h, a phase II trial of sorafenib in patients (pts) with metastatic neuroendocrine tumors (NET): A Phase II Consortium (P2C) study","volume":"25","year":"2007","journal-title":"Journal of Clinical Oncology"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.1090922","article-title":"TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia","volume":"303","year":"2004","journal-title":"Science"},{"key":"ref971","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1136\/gut.52.9.1308","article-title":"Autocrine growth inhibition by transforming growth factor beta-1 (TGFbeta-1) in human neuroendocrine tumour cells","volume":"52","year":"2003","journal-title":"Gut"},{"key":"ref1021","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/1097-0142(19830515)51:10<1918::AID-CNCR2820511027>3.0.CO;2-Y","article-title":"The neuroendocrine products of intestinal carcinoids. An immunoperoxidase study of 35 carcinoid tumors stained for serotonin and eight polypeptide hormones","volume":"51","year":"1983","journal-title":"Cancer"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer.","volume":"16","year":"2016","journal-title":"Nature Reviews Cancer"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1530\/EJE-10-0420","article-title":"Connective tissue growth factor expression in endocrine tumors is associated with high stromal expression of \u03b1-smooth muscle actin","volume":"163","year":"2010","journal-title":"European Journal of Endocrinology"},{"key":"ref861","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM196009222631204","article-title":"Serotonin synthesis in carcinoid patients","volume":"263","year":"1960","journal-title":"New England Journal of Medicine"},{"key":"ref541","first-page":"564","article-title":"Mechanosensory signaling in enterochromaffin cells and 5-HT release: potential implications for gut inflammation","volume":"10","year":"2016","journal-title":"Frontiers in Neuroscience"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1530\/ERC-14-0175","article-title":"Enalapril and ASS inhibit tumor growth in a transgenic mouse model of islet cell tumors","volume":"21","year":"2014","journal-title":"Endocrine-Related Cancer"},{"key":"ref51","first-page":"5253","article-title":"Human carcinoid cell production of paracrine growth factors that can stimulate fibroblast and endothelial cell growth","volume":"51","year":"1991","journal-title":"Cancer Research"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00280-013-2118-9","article-title":"Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors","volume":"71","year":"2013","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"ref1001","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1046\/j.1365-2362.2000.00700.x","article-title":"mRNA expression patterns of insulin-like growth factor system components in human neuroendocrine tumours","volume":"30","year":"2000","journal-title":"European Journal of Clinical Investigation"},{"key":"ref321","first-page":"748","article-title":"Expression of platelet-derived growth factor \u03b2-receptors on stromal tissue cells in human carcinoid tumors","volume":"50","year":"1990","journal-title":"Cancer Research"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1186\/1755-1536-5-S1-S8","article-title":"Connective tissue growth factor in tumor pathogenesis.","volume":"5","year":"2012","journal-title":"Fibrogenesis and Tissue Repair"},{"key":"ref31","first-page":"209","article-title":"Long term treatment with tamoxifen for metastatic carcinoid tumor","volume":"89","year":"1989","journal-title":"Acta Chirurgica Belgica"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1677\/ERC-07-0108","article-title":"Snail and Sonic Hedgehog activation in neuroendocrine tumors of the ileum","volume":"14","year":"2007","journal-title":"Endocrine-Related Cancer"},{"key":"ref771","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1200\/JCO.2005.07.093","article-title":"A multitargeted, metronomic, and maximum-tolerated dose \u2018chemo-switch\u2019 regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer","volume":"23","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"ref671","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1210\/jc.2005-0540","article-title":"Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling","volume":"90","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref821","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1152\/physiolgenomics.00158.2013","article-title":"The wound healing, chronic fibrosis, and cancer progression triad","volume":"46","year":"2014","journal-title":"Physiological Genomics"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1002\/cncr.24533","article-title":"Auto-regulatory effects of serotonin on proliferation and signaling pathways in lung and small intestine neuroendocrine tumor cell lines","volume":"115","year":"2009","journal-title":"Cancer"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s40139-017-0136-8","article-title":"Developmental signaling and organ fibrosis.","volume":"5","year":"2017","journal-title":"Current Pathobiology Reports"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.regpep.2007.02.009","article-title":"Long-term serotonin effects in the rat are prevented by terguride","volume":"143","year":"2007","journal-title":"Regulatory Peptides"},{"key":"ref521","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1478-3231.2005.01057.x","article-title":"Somatostatin inhibits pro-inflammatory cytokine secretion from rat hepatic stellate cells","volume":"25","year":"2005","journal-title":"Liver International"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1200\/jco.2012.30.4_suppl.285","article-title":"A phase II study to evaluate the safety and efficacy of RAD001 plus erlotinib in patients with well-differentiated neuroendocrine tumors (NET)","volume":"30","year":"2012","journal-title":"Journal of Clinical Oncology"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1242\/dmm.004077","article-title":"Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer","volume":"4","year":"2011","journal-title":"Disease Models and Mechanisms"},{"key":"ref991","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1046\/j.1365-2362.1998.00397.x","article-title":"Growth factor receptor expression in human gastroenteropancreatic neuroendocrine tumours.","volume":"28","year":"1998","journal-title":"European Journal of Clinical Investigation"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1309\/AJCPIV40ISTBXRAX","article-title":"Epithelial-mesenchymal transition markers in the differential diagnosis of gastroenteropancreatic neuroendocrine tumors","volume":"140","year":"2013","journal-title":"American Journal of Clinical Pathology"},{"key":"ref961","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/modpathol.2012.143","article-title":"Heterogeneity in signaling pathways of gastroenteropancreatic neuroendocrine tumors: a critical look at notch signaling pathway","volume":"26","year":"2013","journal-title":"Modern Pathology"},{"key":"ref871","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1056\/NEJM198107023050114","article-title":"Tamoxifen in carcinoid syndrome","volume":"305","year":"1981","journal-title":"New England Journal of Medicine"},{"key":"ref981","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1152\/physiol.00045.2009","article-title":"Roles for growth factors in cancer progression.","volume":"25","year":"2010","journal-title":"Physiology"},{"key":"ref751","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000443167","article-title":"ENETS Consensus Guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site","volume":"103","year":"2016","journal-title":"Neuroendocrinology"},{"key":"ref881","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1002\/cncr.25049","article-title":"The 5-HT2B receptor plays a key regulatory role in both neuroendocrine tumor cell proliferation and the modulation of the fibroblast component of the neoplastic microenvironment.","volume":"116","year":"2010","journal-title":"Cancer"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJM196711232772101","article-title":"Inhibition of serotonin synthesis by para-chlorophenylalanine in patients with the carcinoid syndrome","volume":"277","year":"1967","journal-title":"New England Journal of Medicine"},{"key":"ref781","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrc1387","article-title":"Insulin-like growth factors and neoplasia","volume":"4","year":"2004","journal-title":"Nature Reviews Cancer"},{"key":"ref891","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: from development to cancer","volume":"10","year":"2010","journal-title":"Nature Reviews Cancer"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000338793","article-title":"The role of cell lines in the study of neuroendocrine tumors","volume":"96","year":"2012","journal-title":"Neuroendocrinology"},{"key":"ref721","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrc.2016.145","article-title":"Notch as a tumour suppressor.","volume":"17","year":"2017","journal-title":"Nature Reviews Cancer"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1172\/JCI67963","article-title":"The genomic landscape of small intestine neuroendocrine tumors","volume":"123","year":"2013","journal-title":"Journal of Clinical Investigation"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1677\/jme.1.02037","article-title":"Further delineation of the continuous human neoplastic enterochromaffin cell line, KRJ-I, and the inhibitory effects of lanreotide and rapamycin","volume":"38","year":"2007a","journal-title":"Journal of Molecular Endocrinology"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ccell.2017.02.005","article-title":"Nerve dependence: from regeneration to cancer","volume":"31","year":"2017","journal-title":"Cancer Cell"},{"key":"ref171","first-page":"2085","article-title":"Expression of transforming growth factors \u03b21, \u03b22, \u03b23 in neuroendocrine tumors of the digestive system.","volume":"14","year":"1994","journal-title":"Anticancer Research"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-4827(02)00098-8","article-title":"Epidermal growth factor receptor: mechanisms of activation and signalling","volume":"284","year":"2003","journal-title":"Experimental Cell Research"},{"key":"ref381","first-page":"1373","article-title":"Stenting of the superior mesenteric vein in midgut carcinoid disease with large mesenteric masses.","volume-title":"World Journal of Surgery","volume":"34","year":"2010"},{"key":"ref61","first-page":"185.e116","article-title":"Enterochromaffin cells are gut chemosensors that couple to sensory neural pathways","volume":"170","year":"2017","journal-title":"Cell"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bpg.2005.05.007","article-title":"Tumours of the midgut (jejunum, ileum and ascending colon, including carcinoid syndrome)","volume":"19","year":"2005","journal-title":"Best Practice and Research: Clinical Gastroenterology"},{"key":"ref511","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/ajpgi.00146.2005","article-title":"KunnimalaiyaanMTraegerKChenH Conservation of the Notch signaling pathway in gastrointestinal carcinoid cells of and https org","year":"2005","journal-title":"American Journal Physiology Gastrointestinal Liver Physiology"},{"key":"ref841","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2826.2006.01425.x","article-title":"Epidermal growth factor receptor expression and activation in neuroendocrine tumours","volume":"18","year":"2006","journal-title":"Journal of Neuroendocrinology"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/annrheumdis-2016-eular.5587","article-title":"OP0034 the serotonin receptor 2 inhibitor terguride has beneficial effects on skin fibrosis: results from a phase 2 proof of concept study","volume":"75","year":"2016","journal-title":"Annals of the Rheumatic Diseases"},{"key":"ref651","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13069-015-0023-z","article-title":"Modulation of angiotensin II signaling in the prevention of fibrosis","volume":"8","year":"2015","journal-title":"Fibrogenesis and Tissue Repair"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1242\/jcs.03270","article-title":"All in the CCN family: essential matricellular signaling modulators emerge from the bunker","volume":"119","year":"2006","journal-title":"Journal of Cell Science"},{"key":"ref811","article-title":"Mesenteric fibrosis in midgut neuroendocrine tumors: functionality and radiological features.","year":"2017","journal-title":"Neuroendocrinology"},{"key":"ref941","first-page":"4573","article-title":"Insulin-like growth factor-I is an autocrine regulator of chromogranin A secretion and growth in human neuroendocrine tumor cells","volume":"60","year":"2000","journal-title":"Cancer Research"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1200\/JCO.2016.69.2780","article-title":"Telotristat ethyl, a tryptophan hydroxylase inhibitor for the treatment of carcinoid syndrome","volume":"35","year":"2017","journal-title":"Journal of Clinical Oncology"},{"key":"ref831","first-page":"316","article-title":"Biochemical effect of phenylacetic acid in a patient with 5-hydroxytryptophan-secreting carcinoid tumor","volume":"2","year":"1959","journal-title":"Lancet"},{"key":"ref291","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1152\/ajplung.00012.2005","article-title":"mediator of fibrosis or of : and https org","author":"Feghali","year":"2005","journal-title":"carcinogenesis American Journal Physiology Lung Cellular Molecular Physiology"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/02841869309083898","article-title":"Expression of growth factor peptides and their receptors in neuroendocrine tumors of the digestive system","volume":"32","year":"1993","journal-title":"Acta Oncologica"},{"key":"ref601","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1111\/j.1572-0241.2004.40507.x","article-title":"Carcinoid tumors and fibrosis: an association with no explanation","volume":"99","year":"2004","journal-title":"American Journal of Gastroenterology"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation.","volume":"454","year":"2008","journal-title":"Nature"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cytogfr.2004.03.006","article-title":"Regulation of PDGF and its receptors in fibrotic diseases","volume":"15","year":"2004","journal-title":"Cytokine and Growth Factor Reviews"},{"key":"ref1051","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.humpath.2003.12.010","article-title":"The role of \u03b2-catenin, TGF\u03b23, NGF2, FGF2, IGFR2, and BMP4 in the pathogenesis of mesenteric sclerosis and angiopathy in midgut carcinoids","volume":"35","year":"2004","journal-title":"Human Pathology"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1016\/j.humpath.2013.06.019","article-title":"Adenomatous polyposis coli gene involvement in ileal enterochromaffin cell neuroendocrine neoplasms","volume":"44","year":"2013","journal-title":"Human Pathology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/carcin\/bgn171","article-title":"The renin-angiotensin system and malignancy","volume":"29","year":"2008","journal-title":"Carcinogenesis"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.3748\/wjg.v13.i39.5208","article-title":"CTGF, intestinal stellate cells and carcinoid fibrogenesis.","volume":"13","year":"2007c","journal-title":"World Journal of Gastroenterology"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2215\/CJN.09321209","article-title":"Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria","volume":"5","year":"2010","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"ref621","doi-asserted-by":"crossref","first-page":"531","DOI":"10.7326\/0003-4819-100-4-531","article-title":"Tamoxifen therapy for metastatic carcinoid tumor: a negative study","volume":"100","year":"1984","journal-title":"Annals of Internal Medicine"},{"key":"ref921","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1210\/jcem-70-6-1702","article-title":"Plasma substance-P in neuroendocrine tumors and idiopathic flushing: the value of pentagastrin stimulation tests and the effects of somatostatin analog","volume":"70","year":"1990","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00000478-199703000-00009","article-title":"Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in gastrointestinal carcinoids","volume":"21","year":"1997","journal-title":"American Journal of Surgical Pathology"},{"key":"ref641","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2885.2008.00944.x","article-title":"Serotonin: a review","volume":"31","year":"2008","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"ref851","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1159\/000209330","article-title":"KRJ-I and BON cell lines: defining an appropriate enterochromaffin cell neuroendocrine tumor model","volume":"89","year":"2009","journal-title":"Neuroendocrinology"},{"key":"ref741","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2214\/ajr.164.2.7839976","article-title":"Calcification and fibrosis in mesenteric carcinoid tumor: CT findings and pathologic correlation","volume":"164","year":"1995","journal-title":"American Journal of Roentgenology"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrm3434","article-title":"TGFbeta signalling in context","volume":"13","year":"2012","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"ref1011","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","year":"2008","journal-title":"Journal of Pathology"},{"key":"ref901","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7326\/0003-4819-144-2-200601170-00007","article-title":"Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis","volume":"144","year":"2006","journal-title":"Annals of Internal Medicine"},{"key":"ref341","first-page":"15","article-title":"Neuroendocrine tumors show altered expression of chondroitin sulfate, glypican 1, glypican 5, and syndecan 2 depending on their differentiation grade","volume":"4","year":"2014","journal-title":"Frontiers in Oncology"},{"key":"ref691","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/02841869309083899","article-title":"Growth factors and carcinoid tumours","volume":"32","year":"1993","journal-title":"Acta Oncologica"},{"key":"ref731","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1007\/s002680010232","article-title":"Method for dissection of mesenteric metastases in mid-gut carcinoid tumors","volume":"24","year":"2000","journal-title":"World Journal of Surgery"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.2353\/ajpath.2010.100314","article-title":"Substance P modulates colitis-associated fibrosis","volume":"177","year":"2010","journal-title":"American Journal of Pathology"},{"key":"ref711","doi-asserted-by":"crossref","first-page":"34605","DOI":"10.1038\/srep34605","article-title":"IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner","volume":"6","year":"2016","journal-title":"Scientific Reports"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/1097-0142(19910101)67:1<33::AID-CNCR2820670107>3.0.CO;2-E","article-title":"A study of cyproheptadine in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome","volume":"67","year":"1991","journal-title":"Cancer"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1002\/cncr.22725","article-title":"Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor-beta1-mediated regulatory abnormalities including up-regulation of C-Myc and MTA1","volume":"109","year":"2007b","journal-title":"Cancer"},{"key":"ref611","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2036.2009.04174.x","article-title":"Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours","volume":"31","year":"2010","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"ref681","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000443170","article-title":"ENETS Consensus Guidelines update for neuroendocrine neoplasms of the jejunum and ileum.","volume":"103","year":"2016","journal-title":"Neuroendocrinology"},{"key":"ref1031","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u2018carcinoid\u2019: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","year":"2008","journal-title":"Journal of Clinical Oncology"},{"key":"ref141","first-page":"81","article-title":"Transforming growth-factor-alpha and epithelial growth-factor receptor expression in neuroendocrine tumors of the digestive-system.","volume":"3","year":"1993","journal-title":"Diagnostic Oncology"},{"key":"ref911","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/1874312901206010130","article-title":"Role of microRNAs in fibrosis","volume":"6","year":"2012","journal-title":"Open Rheumatology Journal"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1470-2045(17)30110-9","article-title":"Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study","volume":"18","year":"2017","journal-title":"Lancet Oncology"},{"key":"ref561","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.bbadis.2012.09.009","article-title":"Serotonin paracrine signaling in tissue fibrosis","volume":"1832","year":"2013","journal-title":"Biochimica et Biophysica Acta: Molecular Basis of Disease"},{"key":"ref211","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1136\/ard.2009.120196","article-title":"DistlerJHDistlerO Tyrosine kinase inhibitors for the treatment of fibrotic diseases such as systemic sclerosis : towards molecular targeted therapies of the Supplement i i https org","year":"2010","journal-title":"Annals Rheumatic Diseases"},{"key":"ref761","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1200\/jco.2010.28.15_suppl.4001","article-title":"A prospective, multi-institutional phase II study of GW786034 (pazopanib) and depot octreotide (sandostatin LAR) in advanced low-grade neuroendocrine carcinoma (LGNEC)","volume":"28","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1200\/JCO.2007.15.9020","article-title":"Activity of sunitinib in patients with advanced neuroendocrine tumors","volume":"26","year":"2008","journal-title":"Journal of Clinical Oncology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"44735","DOI":"10.18632\/oncotarget.8203","article-title":"Molecular and clinical significance of fibroblast growth factor 2 (FGF2 \/bFGF) in malignancies of solid and hematological cancers for personalized therapies","volume":"7","year":"2016","journal-title":"Oncotarget"},{"key":"ref591","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/archfaci.3.2.111","article-title":"Effect of tamoxifen on transforming growth factor \u03b21 production by keloid and fetal fibroblasts","volume":"3","year":"2001","journal-title":"Archives of Facial Plastic Surgery"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/thx.2007.078006","article-title":"Activation of somatostatin receptors attenuates pulmonary fibrosis","volume":"63","year":"2008","journal-title":"Thorax"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/qjmed\/hcp191","article-title":"Intra-abdominal fibrosis in a recent cohort of patients with neuroendocrine (\u2018carcinoid\u2019) tumours of the small bowel","volume":"103","year":"2010","journal-title":"Quarterly Journal of Medicine"},{"key":"ref801","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00053427","article-title":"Carcinoid syndrome and serotonin: Therapeutic effects of ketanserin","volume":"4","year":"1990","journal-title":"Cardiovascular Drugs and Therapy"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/25\/3\/ERC-17-0380.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1530\/ERC-17-0380","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:54:31Z","timestamp":1784555671000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/erc\/article\/25\/3\/R115-R130\/25159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":106,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1530\/erc-17-0380","relation":{},"ISSN":["1351-0088","1479-6821"],"issn-type":[{"value":"1351-0088","type":"print"},{"value":"1479-6821","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}